Using setbacks as stepping stones in Alzheimer’s research
By Gretta Stone | August 3, 2016
For decades, biopharmaceutical researchers have worked tirelessly in the pursuit of new treatments and cures for the costly and devastating Alzheimer’s disease. Advancing treatments for...
Read More
Biopharmaceutical industry is essential to development of Alzheimer’s treatments
By Holly Campbell | December 23, 2015
This week, presidential candidate Hillary Clinton called for a spending increase by the federal government to find a cure to the costly and devastating Alzheimer’s disease. Finding a better...
Read More
Week in Review: The Latest from PhRMA
By Priscilla VanderVeer | July 17, 2015
Neurological Disorders: America’s biopharmaceutical companies are committed to developing innovative new treatments for the nearly 50 million Americans affected by neurological disorders. This...
Read More
In Case You Missed It: Progress and Promise in Alzheimer’s Research
By Tina Stow | July 15, 2015
PhRMA recently convened a panel of health care experts for a live webcast discussion about the current state of research to treat and care for Alzheimer’s disease. Dr. Bill Chin of PhRMA moderated...
Read More
The War on Alzheimer’s: Progress and Challenges of Biopharmaceutical Research
By Bill Chin, M.D. | July 15, 2015
Alzheimer’s disease steals memories, relationships and independence. It is a ruthless, devastating disease ravaging more than 5 million people in the United States alone, and is the sixth-leading...
Read More
New PhRMA and Epilepsy Foundation Report: 420 Medicines in Development for Neurological Disorders
By Tina Stow | July 13, 2015
It’s hard to imagine, but there are currently more than 50 million Americans – nearly one-sixth of our population – affected by some type of neurological disorder. While some of these are more...
Read More
Week in Review: The Latest from PhRMA
By Priscilla VanderVeer | July 10, 2015
Healthy Outlook: The Cancer Support Community’s Rob Goldsmith highlighted a new report from his organization that found discrepancies in the definition of value in cancer care. July 15 Webcast...
Read More
Alzheimer’s disease has a devastating impact on patients, their loved ones and the caregivers who help them navigate their daily lives. It’s a particularly cruel disease – one that is especially...
Read More
New Video: How Medicines Can Curb Health Care Costs
By Holly Campbell | June 2, 2015
Hospital visits, surgeries and long-term care place a heavy burden on our nation’s health care system, and the weight is only projected to increase. In just the next decade, the U.S. will spend...
Read More
Week in Review: Commitment to Patient Well-Being
By Christian Clymer | January 30, 2015
For the biopharmaceutical industry, patient well-being is at the center of everything we do. In keeping patients at the forefront, we are doing all that we can to help people live longer,...
Read More
Medicare Monday (100)
340B Spotlight (43)
Cost & Consequence (0)
